US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Apr 21, 2022 (4 years ago)

Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented) (Potency expressed as…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

What was recalled

Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented) (Potency expressed as betamethasone), 15 gram tube, Rx Only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-996-65

Recalling firm
McKesson Corporation dba McKesson Drug Company
NDC code
63739-996-65
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0850-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Betamethasone recalls

See all